MedTrace Logo

Customized TULSA-PRO Ablation Registry

NCT05001477 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-11-06

No results posted yet for this study

Summary

This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of their routine clinical care. The registry will shed light on real-world outcomes of safety and efficacy of the procedure and understand how a patient's quality of life is affected throughout their follow-up and lifetime.

Conditions

Interventions

DEVICE

TULSA Procedure

Transurethral ultrasound ablation procedure

Sponsors & Collaborators

  • Profound Medical Inc.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-27
Primary Completion
2026-10-31
Completion
2061-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05001477 on ClinicalTrials.gov